Managing Complications in CKD

  • Published:  25 February 2021
  • Likes: 

    Heart Icon

    4

Up Next

Managing Complications in CKD

  • Published:  25 February 2021
  • Likes: 

    Heart Icon

    4

Average (ratings)
No ratings
Your rating
Overview

This educational symposium was part of the eSPACE CRM meeting held on 22-24 January 2021.

 

The session focuses on novel therapies for Hyperkalaemia and Anaemia.

 

Espace CRM

This symposium was funded by an unrestricted educational grant from AstraZeneca.

Learning objectives

  • Highlight the global burden of CKD and associated complications
  • Discuss the challenges in the current management paradigm for CKD and associated complications, such as RAASi optimisation and iron management
  • Review clinical and mechanistic evidence for the use of novel therapeutic interventions in treating hyperkalaemia and anaemia of CKD, in the context of traditional therapies

Symposium Agenda

  • 10 mins - Welcome and Introductions - Stephen Fishbone
  • 25 mins - Novel therapies for CKD complications: From evidence to practice - Adeera Levin (Canada) & Kieran McCafferty (UK)
  • 20 mins - Panel discussion an Q&A - All faculty, moderated by Stephen Fishbone
  • 5 mins - Future directions and Chair’s summary - All faculty

More from this programme

Part 1

Welcome & Introductions

Part 2

Novel therapies for CKD complications: From evidence to practice

Part 3

Panel discussion an Q&A

Part 4

Future directions and Chair’s summary

Faculty Biographies

Dr Stephen  Fishbane

Dr Stephen Fishbane

Steven Fishbane is the Chief of Nephrology of Northwell Health and Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell. As a nephrologist with over 25 years of clinical experience and as a medical researcher with more than 235 peer-reviewed publications, he understands and has studied many of the issues involved with patient hospitalizations,, readmissions, complications of chronic kidney disease (CKD) and issues with decision making related to end stage kidney disease (ESKD). An important part of his training has been as medical director for 5 different dialysis facilities and as Medical Director for the Healthy Transitions in Advanced Kidney Disease Program. He has been the recipient of multiple honors and holds several appointments, including to the National Quality Forum’s Standing Committee of Admissions and Readmissions. Through his clinical research, Dr. Fishbane has become renowned for advancement and innovation in the treatment of CKD patients.&nbsp…

View full profile
Dr Adeera  Levin

Dr Adeera Levin

Dr. Adeera Levin is a Professor of Medicine, Head Division of Nephrology at the University of British Columbia,  and Consultant nephrologist at Providence Health Care/ St Paul’s Hospital, in Vancouver Canada. She is also the Executive Director of the BC Renal Agency, which oversees the care, planning and budgets for Kidney services in the province of British Columbia. In this capacity, Dr. Levin has leveraged her epidemiological training, clinical knowledge, and health outcomes research to develop an evidence-based transparent system which enhances the care of patients across the continuum of care (from identification of chronic kidney disease [CKD] through to dialysis, transplant, and death).

View full profile
Kieran  McCafferty

Kieran McCafferty

Consultant Nephrologist

Dr Kieran McCafferty is a Consultant Nephrologist at Barts Health NHS Trust and a Senior Lecturer at Queen Mary University of London. His clinical work is focused on the care of patients with complex kidney disease, with particular expertise in diabetic kidney disease and haemodialysis. Alongside his clinical responsibilities, Dr McCafferty has developed a strong academic and leadership profile within nephrology and clinical research, with a clear emphasis on improving patient-centred outcomes through high-quality clinical trials.

 

Academic History

Dr McCafferty holds an academic appointment as Senior Lecturer at Queen Mary University of London, reflecting his combined clinical and research roles. His academic interests bridge basic science and clinical medicine, with a particular focus on uraemic cardiovascular disease and mechanisms of cardiovascular protection in patients with chronic kidney disease.

While his foundational research interests lie…

View full profile